350 related articles for article (PubMed ID: 24390322)
1. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
2. The Feline Immunodeficiency Virus Envelope Signal Peptide Is a Tetherin Antagonizing Protein.
Morrison JH; Poeschla EM
mBio; 2023 Apr; 14(2):e0016123. PubMed ID: 36927083
[TBL] [Abstract][Full Text] [Related]
3. Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.
Dietrich I; McMonagle EL; Petit SJ; Vijayakrishnan S; Logan N; Chan CN; Towers GJ; Hosie MJ; Willett BJ
J Virol; 2011 Jun; 85(12):5840-52. PubMed ID: 21490095
[TBL] [Abstract][Full Text] [Related]
4. Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.
Celestino M; Calistri A; Del Vecchio C; Salata C; Chiuppesi F; Pistello M; Borsetti A; Palù G; Parolin C
J Virol; 2012 Jun; 86(12):6688-700. PubMed ID: 22514338
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of the Ebola Virus Proteins VP40 and GP
Rizk MG; Basler CF; Guatelli J
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
[TBL] [Abstract][Full Text] [Related]
6. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.
Gupta RK; Mlcochova P; Pelchen-Matthews A; Petit SJ; Mattiuzzo G; Pillay D; Takeuchi Y; Marsh M; Towers GJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20889-94. PubMed ID: 19864625
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylation of the feline immunodeficiency virus envelope glycoprotein and its effect on fusion activity and envelope incorporation into virions.
González SA; Paladino MG; Affranchino JL
Virology; 2012 Jun; 428(1):1-10. PubMed ID: 22503389
[TBL] [Abstract][Full Text] [Related]
8. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.
Lucas TM; Janaka SK; Stephens EB; Johnson MC
PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757
[TBL] [Abstract][Full Text] [Related]
9. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.
Le Tortorec A; Neil SJ
J Virol; 2009 Nov; 83(22):11966-78. PubMed ID: 19740980
[TBL] [Abstract][Full Text] [Related]
10. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses.
Lim ES; Malik HS; Emerman M
J Virol; 2010 Jul; 84(14):7124-34. PubMed ID: 20444900
[TBL] [Abstract][Full Text] [Related]
11. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
13. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
[TBL] [Abstract][Full Text] [Related]
14. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
[TBL] [Abstract][Full Text] [Related]
15. Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.
Nikovics K; Dazza MC; Ekwalanga M; Mammano F; Clavel F; Saragosti S
PLoS One; 2012; 7(4):e35411. PubMed ID: 22530020
[TBL] [Abstract][Full Text] [Related]
16. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
17. Feline immunodeficiency virus env gene evolution in experimentally infected cats.
Kraase M; Sloan R; Klein D; Logan N; McMonagle L; Biek R; Willett BJ; Hosie MJ
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):96-106. PubMed ID: 19897254
[TBL] [Abstract][Full Text] [Related]
18. Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.
Yin X; Hu Z; Gu Q; Wu X; Zheng YH; Wei P; Wang X
J Virol; 2014 Jan; 88(2):1259-70. PubMed ID: 24227834
[TBL] [Abstract][Full Text] [Related]
19. Feline immunodeficiency virus (FIV) neutralization: a review.
Hosie MJ; Pajek D; Samman A; Willett BJ
Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.
Chen CY; Shingai M; Welbourn S; Martin MA; Borrego P; Taveira N; Strebel K
J Virol; 2016 Dec; 90(24):11062-11074. PubMed ID: 27681141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
